RECRUITING

NARCOMS Registry: a Multiple Sclerosis Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project is based on the idea that we can learn about the complexities of MS by following disease and treatment patterns in a large group of people over several years. The information gathered is used for research only. Results are presented in summary form only. All details submitted by registry participants is strictly confidential. To participate in NARCOMS complete the baseline enrollment survey online through www.narcoms.org (or directly using the following link: https://redcap.link/py2rnyyn) or you can request a mail-in survey be sent to you by emailing MSregistry@narcoms.org. You will be asked to update your information, online or by mail, twice a year. Each update survey typically takes less than 20 minutes to complete. There is no cost to participate. For your participation you are offered a free subscription to the NARCOMS quarterly magazine, NARCOMS Now. NARCOMS Now provides a reliable source of information about the latest in MS research and disease management. You can stop participating in the registry at any time. You may also receive additional surveys or information on clinical trials. You are not obligated to participate and these additional studies will always come directly from NARCOMS. Your contact information will not be shared or sold to other parties.

Official Title

NARCOMS Global Multiple Sclerosis Registry: a Long-Term Study to Facilitate Research in Multiple Sclerosis

Quick Facts

Study Start:1996-01
Study Completion:2050-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01018537

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Any individual who has been diagnosed with multiple sclerosis or clinically isolated syndrome
  2. * Must be at least 18 years of age
  1. * None

Contacts and Locations

Study Contact

NARCOMS Team
CONTACT
1-214-648-4583
MSregistry@narcoms.org

Principal Investigator

Robert J. Fox, M.D.
STUDY_DIRECTOR
Mellen Center for MS / Cleveland Clinic
Amber Salter, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Texas Southwestern Medical Center
Gary R Cutter, Ph.D.
STUDY_DIRECTOR
University of Alabama at Birmingham
Ruth Ann Marrie, M.D., Ph.D.
STUDY_DIRECTOR
Dalhousie University

Study Locations (Sites)

UT Southwestern Medical Center
Dallas, Texas, 75390-8806
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

  • Robert J. Fox, M.D., STUDY_DIRECTOR, Mellen Center for MS / Cleveland Clinic
  • Amber Salter, Ph.D., PRINCIPAL_INVESTIGATOR, University of Texas Southwestern Medical Center
  • Gary R Cutter, Ph.D., STUDY_DIRECTOR, University of Alabama at Birmingham
  • Ruth Ann Marrie, M.D., Ph.D., STUDY_DIRECTOR, Dalhousie University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date1996-01
Study Completion Date2050-12

Study Record Updates

Study Start Date1996-01
Study Completion Date2050-12

Terms related to this study

Keywords Provided by Researchers

  • Multiple Sclerosis
  • NARCOMS
  • Patient Registry
  • Registry

Additional Relevant MeSH Terms

  • Multiple Sclerosis